Michael Shetzline, SVP, CMO, Head-Res&Drug: Ironwood Pharmaceuticals IRWD Sell · Filed 02/25

Trade details

Type: Insider sale
Amount: $59,321.7
Shares · price: 15,570 sh · $3.81 a share
Held after: 538,437 sh
Stock: Ironwood Pharmaceuticals IRWD
Person: Michael ShetzlineSVP, CMO, Head-Res&Drug
Trade date: 26/02/23
Filed: 26/02/25
Days to filing: 2 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Ironwood Pharmaceuticals trades, last 26 weeks

What else happened in Ironwood Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/24~03/25

Michael Shetzline's recent trades

Michael ShetzlineSVP, CMO, Head-Res&Drug
Planned saleIronwood Pharmaceuticals
Planned sale
Ironwood Pharmaceuticals
IRWD
$377.4K
83,306 sh
$377.4K
Filed 09/23
Traded 09/24
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$62.3K
17,012 sh
$62.3K
Filed 02/25
Traded 02/24
Michael ShetzlineSVP, CMO, Head-Res&Drug
Planned saleIronwood Pharmaceuticals
Planned sale
Ironwood Pharmaceuticals
IRWD
$138K
29,937 sh
$138K
Filed 02/20
Traded 02/23
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$72.6K
41,269 sh
$72.6K
Filed 25/02/12
Traded 25/02/10
Michael ShetzlineOfficer
Planned saleIronwood Pharmaceuticals
Planned sale
Ironwood Pharmaceuticals
IRWD
$82K
42,274 sh
$82K
Filed 25/02/07
Traded 25/02/10

Michael Shetzline, CMO — sold $59.3K of Ironwood Pharmaceuticals IRWD · 2.8% of holdings | Whalegun